Metro Healthcare Indonesia (CARE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Metro Healthcare Indonesia (CARE) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp16.50 Billion ≈ $967.04K USD) by net assets (Rp3.02 Trillion ≈ $177.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CARE net asset quality score to measure how much of total assets are equity-financed.
Metro Healthcare Indonesia - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Metro Healthcare Indonesia's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Metro Healthcare Indonesia to evaluate the quality of earnings relative to operating cash generation.
Metro Healthcare Indonesia Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Metro Healthcare Indonesia ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bafang Electric Suzhou Co Ltd
SHG:603489
|
0.017x |
|
Archicom S.A.
WAR:ARH
|
0.087x |
|
Flowco Holdings Inc.
NYSE:FLOC
|
0.059x |
|
Luoniushan Co Ltd
SHE:000735
|
0.012x |
|
Shanghai Emperor of Cleaning Hi-Tech Co Ltd
SHG:603200
|
0.010x |
|
Anhui Gujing Distillery Co Ltd
SHE:200596
|
-0.054x |
|
Ubisoft Entertainment
PA:UBI
|
0.390x |
|
DLG Exhibitions & Events Corp Ltd
SHG:600826
|
0.045x |
Annual Cash Flow Conversion Efficiency for Metro Healthcare Indonesia (2016–2024)
The table below shows the annual cash flow conversion efficiency of Metro Healthcare Indonesia from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Metro Healthcare Indonesia (CARE) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp3.02 Trillion ≈ $176.87 Million |
Rp-113.01 Billion ≈ $-6.62 Million |
-0.037x | -39.68% |
| 2023-12-31 | Rp3.10 Trillion ≈ $181.51 Million |
Rp-83.03 Billion ≈ $-4.87 Million |
-0.027x | +8.17% |
| 2022-12-31 | Rp3.21 Trillion ≈ $187.91 Million |
Rp-93.60 Billion ≈ $-5.48 Million |
-0.029x | -304.27% |
| 2021-12-31 | Rp3.30 Trillion ≈ $193.27 Million |
Rp47.13 Billion ≈ $2.76 Million |
0.014x | -6.52% |
| 2020-12-31 | Rp3.29 Trillion ≈ $192.83 Million |
Rp50.30 Billion ≈ $2.95 Million |
0.015x | +251.23% |
| 2019-12-31 | Rp2.27 Trillion ≈ $133.20 Million |
Rp-22.98 Billion ≈ $-1.35 Million |
-0.010x | -100.95% |
| 2018-12-31 | Rp-27.14 Billion ≈ $-1.59 Million |
Rp-29.03 Billion ≈ $-1.70 Million |
1.069x | +170.88% |
| 2017-12-31 | Rp11.34 Billion ≈ $664.19K |
Rp-17.10 Billion ≈ $-1.00 Million |
-1.509x | -1462248.40% |
| 2016-12-31 | Rp10.62 Billion ≈ $622.43K |
Rp-1.10 Million ≈ $-64.22 |
0.000x | -- |
About Metro Healthcare Indonesia
PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It provides the management of hospitals, clinics, treatment hall, polyclinics, and other medical centers; physical medicine and trading; industry, development, and services; professional, scientific, technical, financial, and investment services; transportation, workshop, forestry, and agriculture services; heal… Read more